SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+31.2%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(+26%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-15.61%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
104
New
30
Increased
28
Reduced
25
Closed
13
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$43.7M |
| 2 |
TG Therapeutics
TGTX
|
$38.3M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$23.2M |
| 4 |
Keros Therapeutics
KROS
|
$18.1M |
| 5 |
Biogen
BIIB
|
$15.7M |
Top Sells
| 1 |
Jasper Therapeutics
JSPR
|
$255M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$46.4M |
| 3 |
GSK
GSK
|
$41.1M |
| 4 |
Viking Therapeutics
VKTX
|
$30.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$29.3M |
Sector Composition
| 1 | Healthcare | 99.93% |
| 2 | Consumer Staples | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Arcutis Biotherapeutics
ARQT
$1.86B
| $2.23M | 0.17% | +225,000 | New | +$2.23M |
|
77
Annexon
ANNX
$226M
| $2.1M | 0.16% | 292,400 -223,000 | -43% | -$1.6M |
|
78
Apogee Therapeutics
APGE
$2.17B
| $1.33M | 0.1% | 20,000 -15,000 | -43% | -$997K |
|
79
Transmedics
TMDX
$3.92B
| $1.23M | 0.09% | 16,700 -106,412 | -86% | -$7.87M |
|
80
Avita Medical
RCEL
$117M
| $1.2M | 0.09% | 75,000 | – | – |
|
81
Protagonist Therapeutics
PTGX
$3.67B
| $998K | 0.07% | 34,500 -48,500 | -58% | -$1.4M |
|
82
Denali Therapeutics
DNLI
$2.23B
| $964K | 0.07% | 47,000 -83,000 | -64% | -$1.7M |
|
83
CVRx
CVRX
$205M
| $883K | 0.07% | +48,500 | New | +$883K |
|
84
The Beauty Health Co
SKIN
$264M
| $755K | 0.06% | 170,000 +15,000 | +10% | +$66.6K |
|
85
Amicus Therapeutics
FOLD
$2.34B
| $683K | 0.05% | +57,966 | New | +$683K |
|
86
Tenaya Therapeutics
TNYA
$184M
| $639K | 0.05% | +122,222 | New | +$639K |
|
|
SILK
87
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $183K | 0.01% | 10,000 -527,000 | -98% | -$9.65M |
|
88
UroGen Pharma
URGN
$900M
| $150K | 0.01% | +10,000 | New | +$150K |
|
89
Liquidia Corp
LQDA
$2.38B
| $148K | 0.01% | 10,000 | – | – |
|
90
Xeris Biopharma Holdings
XERS
$1.26B
| $137K | 0.01% | 62,083 | – | – |
|
91
AbbVie
ABBV
$372B
| – | – | -14,800 | Closed | -$2.29M |
|
92
Adverum Biotechnologies
ADVM
$64.6M
| – | – | -425,000 | Closed | -$320K |
|
93
AtriCure
ATRC
$1.84B
| – | – | -392,195 | Closed | -$14M |
|
94
CVS Health
CVS
$92.8B
| – | – | -59,500 | Closed | -$4.7M |
|
95
Hologic
HOLX
$14.9B
| – | – | -34,000 | Closed | -$2.43M |
|
96
Illumina
ILMN
$15.8B
| – | – | -5,300 | Closed | -$738K |
|
97
SI-BONE Inc
SIBN
$719M
| – | – | -341,818 | Closed | -$7.17M |
|
98
Smith & Nephew
SNN
$16.3B
| – | – | -470,198 | Closed | -$12.8M |
|
99
VYNE Therapeutics
VYNE
$8.16M
| – | – | -703,868 | Closed | -$1.64M |
|
100
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|